[1] P. K. Tosh, et al., “Outbreak of Pseudomonas aeruginosa Surgical Site Infections after Arthroscopic Procedures: Texas, 2009,” Infection Control and Hospital Epidemiology, Vol. 32, No. 12, 2011, pp. 179-186. doi:10.1086/662712
[2] J. Eaton, “Filthy Surgical Instruments: The Hidden Threat in America’s Operating Rooms. How Dirty Medical Devices Expose Patients to Infection,” The Center for Public Integrity, Washington DC, 2012.
[3] Food and Drug Administration (FDA), “Ongoing Safety Review of Arthroscopic Shavers,” Safety Communications, 2009.
[4] Food and Drug Administration (FDA), “Formula 180 Shaver Handpeice. Manufacturer: Stryker Endoscopy,” Manufacturer and User Facility Device Experience Event, 2009.
[5] Stryker Endoscopy, “Class 2 Recall: Inflow/Outflow Cannula,” Medical Device Recalls, 2013.
[6] The NBC Nightly News, “Dirty Surgical Tools Put Patients at Risk,” 2012.
[7] Fox News, “Report: Dirty Surgical Tools in Hospitals Putting Patients at Risk,” 2012.
[8] Food and Drug Administration (FDA), “Sterrad NX Sterilizer (Manufacturer: Advanced Sterilization Products),” Manufacturer and User Facility Device Experience (MAUDE) Event, 2010.
[9] M. Sorin, et al., “Nosocomial Transmission of Imipenem-Resistant Pseudomonas aeruginosa Following Bronchoscopy Associated with Improper Connection to the Steris System 1 Processor,” Infection Control and Hospital Epidemiology, Vol. 22, No. 7, 2001, pp. 409-413. doi:10.1086/501925
[10] L. F. Muscarella, “Leading a Horse to Water: Are Crucial Lessons in Endoscopy and Outbreak Investigations Being Learned?” Infection Control and Hospital Epidemiology, Vol. 23, No. 7, 2002, pp. 358-360. doi:10.1086/503469
[11] P. Davies, “Germ Watch: Clinic Infections Put a Sterilizer of Lab Devices under Microscope,” The Wall Street Journal, 2004.
[12] C. J. Alvarado, S. M. Stolz and D. G. Maki, “Nosocomial Infections from Contaminated Endoscopes: A Flawed Automated Endoscope Washer. An Investigation Using Molecular Epidemiology,” The American Journal of Medicine, Vol. 91, No. 3, 1991, pp. 272S-280S. doi:10.1016/0002-9343(91)90381-7
[13] Centers for Disease Control and Prevention (CDC), “Pseudomonas aeruginosa Infections Associated with Transrectal Ultrasound-Guided Prostate Biopsies—Georgia, 2005,” Morbidity and Mortality Weekly Report, Vol. 55, No. 28, 2006, pp. 776-777.
[14] L. F. Muscarella, “Medical Errors, Infection-Control Breaches and the Use of Adulterated and Misbranded Medical Devices,” World Journal of Clinical Infectious Diseases, Vol. 2, No., 2, 2012, pp. 13-27.
[15] M. J. Struelen, F. Rost, A. Deplano, et al., “Pseudomonas aeruginosa and Enterobacteriaceae bacteremia after Biliary Endoscopy: An Outbreak Investigation Using DNA Macrorestriction Analysis,” The American Journal of Medicine, Vol. 95, No. 5, 1993, pp. 489-498. doi:10.1016/0002-9343(93)90331-I
[16] H. J. Kolmos, et al., “Pseudo-Outbreak of Pseudomonas aeruginosa in HIV-Infected Patients Undergoing Fiberoptic Bronchoscopy,” Scandinavian Journal of Infectious Diseases, Vol. 26, No. 6, 1994, pp. 653-657. doi:10.3109/00365549409008632
[17] L. F. Muscarella, “Contribution of Tap Water and Environmental Surfaces to Nosocomial Transmission of Antibiotic-Resistant Pseudomonas aeruginosa,” Infection Control and Hospital Epidemiology, Vol. 25, No. 4, 2004, pp. 342-345. doi:10.1086/502402
[18] Centers for Disease Control and Prevention (CDC), “Guideline for Disinfection and Sterilization in Healthcare Facilities,” 2008, pp. 1-158.
[19] Association of Perioperative Registered Nurses (AORN), “Perioperative Standards and Recommended Practices,” Denver, 2005.
[20] C. R. Voyles, et al., “Steam Sterilization of Laparoscopic Instruments,” Surgical Laparoscopy Endoscopy, Vol. 5, No. 2, 1995, 139-141.
[21] W. A. Rutala, M. F. Gergen and D. J. Weber, “Impact of an Oil-Based Lubricant on the Effectiveness of the Sterilization Processes,” Infection Control and Hospital Epidemiology, Vol. 29, No. 1, 2008, pp. 69-72. doi:10.1086/524326
[22] F. T. Blevins, et al., “Septic Arthritis Following Arthroscopic Meniscus Repair: A Cluster of three Cases,” Arthroscopy, Vol. 15, No. 1, 1999, pp. 35-40. doi:10.1053/ar.1999.v15.015003
[23] S. A. McNeil, et al., “Outbreak of Sternal Surgical Site Infections Due to Pseudomonas aeruginosa Traced to a Scrub Nurse with Onychomycosis,” Clinical Infectious Diseases, Vol. 33, No. 3, 2001, pp. 317-323. doi:10.1086/321890
[24] R. L. Moolenaar, et al., “A Prolonged Outbreak of Pseudomonas aeruginosa in a Neonatal Intensive Care Unit: Did Staff Fingernails Play a Role in Disease Transmission?” Infection Control and Hospital Epidemiology, Vol. 21, No. 2, 2000, pp. 80-85. doi:10.1086/501739
[25] A. F. Widmer, et al., “Outbreak of Pseudomonas aeruginosa Infections in a Surgical Intensive Care Unit: Probable Transmission via Hands of a Health Care Worker,” Clinical Infectious Diseases, Vol. 16, No. 3, 1993, pp. 372-376. doi:10.1093/clind/16.3.372
[26] X. Bertrand, et al., “Large Outbreak in a Surgical Intensive Care Unit of Colonization or Infection with Pseudomonas aeruginosa That Overexpressed an Active Efflux Pump,” Clinical Infectious Diseases, Vol. 31, No. 4, 2000, pp. E9-E14. doi:10.1086/318117
[27] A. M. Rogues, et al., “Contribution of Tap Water to Patient Colonisation with Pseudomonas aeruginosa in a Medical Intensive Care Unit,” Journal of Hospital Infection, Vol. 67, No. 1, 2007, pp. 72-78. doi:10.1016/j.jhin.2007.06.019
[28] D. Mayank et al., “Nosocomial Cross-Transmission of Pseudomonas aeruginosa between Patients in a Tertiary Intensive Care Unit,” Indian Journal of Pathology and Microbiologyl, Vol. 52, No. 4, 2009, pp. 509-513. doi:10.4103/0377-4929.56143
[29] S. Hota, et al., “Outbreak of Multidrug-Resistant Pseudomonas aeruginosa Colonization and Infection Secondary to Imperfect Intensive Care Unit Room Design,” Infection Control and Hospital Epidemiology, Vol. 30, No. 1, 2009, pp. 25-33. doi:10.1086/592700
[30] C. Lowe, et al., “Outbreak of Extended-Spectrum β-Lactamase-Producing Klebsiella oxytoca Infections Associated with Contaminated Handwashing Sinks,” Emerging Infectious Diseases, Vol. 18, No. 8, 2012, pp. 1242-1247. doi:10.3201/eid1808.111268
[31] D. M. Dudzinski, et al., “The Disclosure Dilemma— Large-Scale Adverse Events,” The New England Journal of Medicine, Vol. 363, No. 10, 2010, pp. 978-986. doi:10.1056/NEJMhle1003134
[32] Food and Drug Administration, “Establishment Inspection Report: Stryker Endoscopy,” Inspection, San Jose, 2009.
[33] L. F. Muscarella, “Instrument Design and Cross-Infection,” AORN Journal, Vol. 67, No. 3, 1998, pp. 552-553, 556. doi:10.1016/S0001-2092(06)62824-X
[34] L. F. Muscarella, “Are All Sterilization Processes Alike?” AORN Journal, Vol. 67, No. 5, 1998, pp. 966-970, 973-976. doi:10.1016/S0001-2092(06)62622-7
[35] L. F. Muscarella, “The Importance of Bronchoscope Reprocessing Guidelines: Raising the Standard of Care,” Chest, Vol. 126, No. 3, 2004, pp. 1001-2; reply, pp. 1002-1003.
[36] L. F. Muscarella, “Application of Environmental Sampling to Flexible Endoscope Reprocessing: The Importance of Monitoring the Rinse Water,” Infection Control and Hospital Epidemiology, Vol. 23, No. 5, 2002, pp. 285-289. doi:10.1086/502053